120 related articles for article (PubMed ID: 15115305)
21. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of osteopontin/Eta-1 in early and late lpr disease.
Weber GF; Cantor H
Clin Exp Immunol; 2001 Dec; 126(3):578-83. PubMed ID: 11737079
[TBL] [Abstract][Full Text] [Related]
23. Effects of the lpr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site.
Aicher WK; Fujihashi K; Yamamoto M; Kiyono H; Pitts AM; McGhee JR
Int Immunol; 1992 Sep; 4(9):959-68. PubMed ID: 1390438
[TBL] [Abstract][Full Text] [Related]
24. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
25. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
Drappa J; Brot N; Elkon KB
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
[TBL] [Abstract][Full Text] [Related]
26. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
27. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
Balomenos D; Rumold R; Theofilopoulos AN
J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
[TBL] [Abstract][Full Text] [Related]
28. Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
Izawa T; Kondo T; Kurosawa M; Oura R; Matsumoto K; Tanaka E; Yamada A; Arakaki R; Kudo Y; Hayashi Y; Ishimaru N
PLoS One; 2012; 7(12):e48798. PubMed ID: 23300516
[TBL] [Abstract][Full Text] [Related]
29. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
30. Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells.
Komano H; Ikegami Y; Yokoyama M; Suzuki R; Yonehara S; Yamasaki Y; Shinohara N
Int Immunol; 1999 Jul; 11(7):1035-42. PubMed ID: 10383935
[TBL] [Abstract][Full Text] [Related]
31. Transgenic expression of the viral FLIP MC159 causes lpr/gld-like lymphoproliferation and autoimmunity.
Woelfel M; Bixby J; Brehm MA; Chan FK
J Immunol; 2006 Sep; 177(6):3814-20. PubMed ID: 16951343
[TBL] [Abstract][Full Text] [Related]
32. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
Corneth OBJ; Schaper F; Luk F; Asmawidjaja PS; Mus AMC; Horst G; Heeringa P; Hendriks RW; Westra J; Lubberts E
Sci Rep; 2019 Mar; 9(1):4032. PubMed ID: 30858513
[TBL] [Abstract][Full Text] [Related]
33. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
34. An allogeneic microenvironment influences the phenotype of intermediate T-cell receptor cells expanding in MRL-lpr/lpr mice.
Tsukahara A; Iiai T; Moroda T; Tada T; Suzuki S; Takeda K; Hatakeyama K; Abo T
Immunology; 1998 Jun; 94(2):149-59. PubMed ID: 9741335
[TBL] [Abstract][Full Text] [Related]
35. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
[TBL] [Abstract][Full Text] [Related]
36. Requirement of Fas expression in B cells for tolerance induction.
Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
Eur J Immunol; 2002 Jan; 32(1):223-30. PubMed ID: 11782013
[TBL] [Abstract][Full Text] [Related]
37. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
[TBL] [Abstract][Full Text] [Related]
38. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
39. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro.
Wilson DA
Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418
[TBL] [Abstract][Full Text] [Related]
40. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
